Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America

— —

K. Rajender Reddy (Director of Hepatology, Hospital of the University of Pennsylvania, GI Division, Philadelphia, PA)

Hepatitis C Virus

The Next Epidemic, An issue of Gastroenterology Clinics of North America

K. Rajender Reddy (Director of Hepatology, Hospital of the University of Pennsylvania, GI Division, Philadelphia, PA)

$163.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Elsevier - Health Sciences Division
07 December 2015

Hepatology

Series: The Clinics: Internal Medicine

Summary
Details

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.

This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

By: K. Rajender Reddy (Director of Hepatology Hospital of the University of Pennsylvania GI Division Philadelphia PA)
Imprint: Elsevier - Health Sciences Division
Country of Publication: United States
Volume: 44-4
Dimensions: Height: 229mm, Width: 152mm,
Weight: 540g
ISBN: 9780323402484
ISBN 10: 0323402488
Series: The Clinics: Internal Medicine
Publication Date: 07 December 2015
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Hepatitis C Virus

The Next Epidemic, An issue of Gastroenterology Clinics of North America

K. Rajender Reddy (Director of Hepatology, Hospital of the University of Pennsylvania, GI Division, Philadelphia, PA)

$163.95

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S